The battle for supremacy for hearts, minds, knees, joints, skin and much more!
Canadians are looking enviously across the border and wondering when they might get access to CBD, this “magic” cannabinoid molecule touted as a cure-all for so many health ailments. Yet there is already a molecule that has been available to many Canadians (for nearly three years!) which has a far better clinical and safety track-record, and without any of the negative stigma associated with cannabis from which CBD is derived.
Let us compare and contract both molecules:
| CBD | PEA |
| Derived from cannabis/ hemp | Sunflower lecithin |
| Little research | Studied for 80 years |
| Questionable science | Good science |
| Few human published studies | Widely published |
| Pain and epilepsy | Pain, analgesia, inflammation, cognition, autism, heart disease, depression, stress and many other areas |
| Large variability in dose to produce an effect 10 mg to 1200 mg | Defined dose 1200mg per day |
| Externally derived (exo-cannabinoid) | Produced by the body (endocannabinoid-like molecule) |
| Can persist in the body | Only produced when there is demand |
| May cause side-effects | No side-effects reported |
| Body does not have any deficiency | Specific conditions where there is deficiency |
| CBD not a marker for any diseases | PEA likely to be a marker for host of conditions |
In summary, PEA is a natural molecule that the body turns to when it is in danger, disease and after damage. Moreover, once the PEA has performed its action it disappears quietly as it first appears like a true superhero without any fanfare.
There may be certain diseases like IBD, other gut conditions, fibromyalgia, certain stress conditions and hormonal conditions where there is a deficiency state of PEA and where supplementation is required. Unlike CBD, where no deficiency state has been identified.
Store Locator
Back
